Flatiron Health today announced eight abstracts were accepted for presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program , to be held May 29–31. “ The research being presented displays the broad impact that real-world data derived from electronic health records has across the oncology therapeutic lifecycle from discovery through development and ultimately in support of patient care,” said Dr. Michael Vasconcelles, chief medical officer at Flatiron. “It is a rich illustration of the knowledge that can be created when experts collaborate across the oncology ecosystem.” The key areas studied include:
-
Biomarkers that predict who may benefit from targeted treatments
-
Treatment patterns at the end of life
-
Barriers and solutions to clinical trial participation
-
Novel clinico-genomic research
Flatiron collaborated on the accepted research with: University of Pennsylvania, Yale Cancer Center, Cancer & Hematology Centers of Western Michigan, Florida Cancer Specialists, Hematology Oncology Associates of Central New York, Southeast Nebraska Cancer Center, Tennessee Oncology, West Cancer Center, Foundation Medicine, and Genentech, a member of the Roche Group.
Poster Presentations
First Author: Deborah B. Doroshow, Icahn School of Medicine at Mount Sinai
Abstract: 9539
Poster: 305
First Author: Emmanuel S. Antonarakis, Sidney Kimmel Comprehensive Cancer Center
Abstract: 5527
Poster: 108
First Author: Johnetta Blakely, Tennessee Oncology
Abstract: 2061
Poster: 5
The adoption of immune checkpoint inhibitors and patterns of care at the end of life
First Author: Fauzia Riaz, Yale School of Medicine
Abstract: 12027
Poster: 315
First Author: Michael W. Lu, Genentech
Abstract: TPS2087
Poster: 79
First Author: Jeffrey J. Kirshner, Hematology Oncology Associates of Central New York
Abstract: 2051
Poster: 43
First Author: Tamara Snow, Flatiron Health
Abstract: 3060
Poster: 124
First Author: Sai-Hong I. Ou, University of California Irvine Chao Comprehensive Cancer Center
Abstract: 9591
Poster: 357
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
Location:
NEW YORK, NY, May 14, 2020